🔗 Share this article Individuals Discontinuing Anti-Obesity Medications Gain Back Pounds Four Times Faster Than People Using Diet and Exercise Obesity treatment involves ongoing approaches. New research suggests that individuals who come off new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who end conventional diet and exercise regimens. Research printed in a prominent health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation. "Individuals purchasing such drugs should be informed of the potential of rapid rebound weight gain when the therapy ends," cautioned lead investigator Dr. Susan Jebb. That rate of recovery means a return to pre-treatment mass in about one and a half years. Analyzing Treatments The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of these new drugs with older methods. Scientists note that people who lose weight through dieting generally experience a less rapid creep back—perhaps 0.1 kg a month—post-intervention. Understanding the Rapid Rebound Nutrition scientists believe the way of the injections is key to understanding the amplified weight return. These medications imitate a natural hormone called GLP-1, which controls appetite. "Long-term administration of the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist. "Discontinuation of this hormone supplement results in hunger is unsuppressed, making excessive eating a significant risk." A Chronic Disease? The NHS advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes. Professionals contend that, due to the high risk of weight regain, the treatment is often ongoing. This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of excess weight," akin to managing conditions like hypertension. User Accounts People who have stopped the medication report a powerful resurgence of appetite. "It was like a switch flipping and you become starving," said an individual. This challenge is exacerbated if individuals have not established lasting dietary or behavioural changes during therapy. Growing Use Survey data show that a significant number of people in the UK have used these injections in the past year, with demand being substantial. Use is higher among women compared to men. The 40s and 50s demographic shows the greatest usage rates. Many access the drugs through private prescriptions rather than the NHS. In conclusion, clinicians stress that while the jabs are powerful agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing behavioural changes.
Obesity treatment involves ongoing approaches. New research suggests that individuals who come off new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who end conventional diet and exercise regimens. Research printed in a prominent health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation. "Individuals purchasing such drugs should be informed of the potential of rapid rebound weight gain when the therapy ends," cautioned lead investigator Dr. Susan Jebb. That rate of recovery means a return to pre-treatment mass in about one and a half years. Analyzing Treatments The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of these new drugs with older methods. Scientists note that people who lose weight through dieting generally experience a less rapid creep back—perhaps 0.1 kg a month—post-intervention. Understanding the Rapid Rebound Nutrition scientists believe the way of the injections is key to understanding the amplified weight return. These medications imitate a natural hormone called GLP-1, which controls appetite. "Long-term administration of the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist. "Discontinuation of this hormone supplement results in hunger is unsuppressed, making excessive eating a significant risk." A Chronic Disease? The NHS advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes. Professionals contend that, due to the high risk of weight regain, the treatment is often ongoing. This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of excess weight," akin to managing conditions like hypertension. User Accounts People who have stopped the medication report a powerful resurgence of appetite. "It was like a switch flipping and you become starving," said an individual. This challenge is exacerbated if individuals have not established lasting dietary or behavioural changes during therapy. Growing Use Survey data show that a significant number of people in the UK have used these injections in the past year, with demand being substantial. Use is higher among women compared to men. The 40s and 50s demographic shows the greatest usage rates. Many access the drugs through private prescriptions rather than the NHS. In conclusion, clinicians stress that while the jabs are powerful agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing behavioural changes.